Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

The introduction of vaccination programs against measles, mumps, and rubella (MMR) led to significant global reduction in morbidity and mortality from these diseases. The currently recommended MMR vaccination schedule in the United States of America comprises 2 vaccine doses typically administered a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Remon Abu-Elyazeed (Autor), William Jennings (Autor), Randall Severance (Autor), Michael Noss (Autor), Adrian Caplanusi (Autor), Michael Povey (Autor), Ouzama Henry (Autor)
Format: Knjiga
Izdano: Taylor & Francis Group, 2018-11-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno